ADAR1 Capital Management, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value (IKT)

Filing Manager
ADAR1 Capital Management, LLC
Reporting Manager
ADAR1 Capital Management GP, LLC
Security
Inhibikase Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
IKT
Shares outstanding
78,158,525 shares
Disclosed Ownership
7,737,694 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 20:27:41 UTC
Date of event
30 Jun 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ADAR1 Capital Management, LLC 9.9% 7,682,503 0 7,682,503 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
ADAR1 Capital Management GP, LLC 9.9% 7,737,694 0 7,737,694 /s/ Daniel Schneeberger Daniel Schneeberger, Manager
Daniel Schneeberger 9.9% 7,682,503 0 7,682,503 /s/ Daniel Schneeberger Daniel Schneeberger, in his individual capacity